Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 28Prostatic Neoplasms 14Neoplasm Metastasis 12Osteoporosis 8Multiple Myeloma 8Pain 7Lung Neoplasms 4Fractures, Bone 4Carcinoma, Non-Small-Cell Lung 4Neoplasms, Plasma Cell 3Humoral Hypercalcemia Of Malignancy 3Bone Neoplasms 3Bone Diseases, Metabolic 3Spinal Cord Compression 2Neoplasms 2Lymphoma 2Hematologic Neoplasms 2Triple Negative Breast Neoplasms 1Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Paraproteinemias 1Osteosarcoma 1Neoplastic Processes 1Lymphoma, Non-Hodgkin 1Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1Hematologic Diseases 1Giant Cell Tumor of Bone 1Disease Progression 1

Interventions

Denosumab 2Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Giant Cell Tumor of Bone × Zoledronic Acid × Clear all
NCT03295981 2026-04-22

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

St. Louis University

Phase 3 Recruiting
120 enrolled

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡